Skip to main content
FinSpry Logo
FinSpry
NRIX logo
NRIX
(NASDAQ)
Nurix Therapeutics, Inc.
$15.51-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Nurix Therapeutics (NRIX) Stock Price & Financial Analysis

Nurix Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$15.00 - $15.65
52-Week High$22.50
52-Week Low$8.18
Open$15.22
Volume1.17M
Average Volume (3M)1.17M
Market Cap1.34B
Shares Outstanding86.67M
Price to Sales (P/S)15.98
Price to Book (P/B)2.49
EV/EBITDA-4.31
Revenue (TTM)83.98M
Net Income (TTM)-264.46M
Free Cash Flow (TTM)-263.47M
EPS (TTM)$-2.78
Profit Margin-314.90%
Operating Margin-340.16%
Return on Equity (ROE)-49.09%
Debt to Equity0.10
50-Day MA$16.10
200-Day MA$13.64
52-Week Change47.85%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Nurix Therapeutics

What is the current stock price for NRIX?

As of the latest trading session, NRIX stock trades at $15.51. The 52-week range is $8.18–$22.50, with a day range of $15.00–$15.65.

What is the P/E ratio for NRIX?

The P/E ratio (Price-to-Earnings) for NRIX is shown in the Key Statistics section. This valuation metric helps compare Nurix Therapeutics, Inc. to industry peers.

Does NRIX pay dividends?

Nurix Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NRIX?

Based on 8 analysts, the consensus for NRIX is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NRIX?

Nurix Therapeutics's market capitalization is $1.34B, classifying it as a small-cap company. Nurix Therapeutics operates in the Healthcare sector within the Biotechnology industry.